Zeria Pharmaceutical Co. Ltd. vs. The Controller of Patents
A recent Delhi High Court judgment in Zeria Pharmaceutical Co. Ltd. vs. The Controller of Patents (C.A.(COMM.IPD-PAT) 452/2022) delivers a message to the pharmaceutical industry: a higher yield and greater purity are not enough to secure a patent in India. Zeria’s patent application for a novel intermediate compound was rejected by the Indian Patent Office, … Read more